Suministro Medicamentos Hospital del Salvador
Mantener suministro de stock de medicamentos para pacientes del Hospital del Salvador
25 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 900-778-SE24 | 03-07-2024 | Laboratorios Recalcine S.A. | $2.349.060 |
| 900-771-SE24 | 03-07-2024 | Guillermo Harding y Compania Limitada | $6.601.573 |
| 900-652-SE24 | 05-06-2024 | Ethon Pharmaceuticals Ltda. | $3.927.000 |
| 900-666-SE24 | 04-06-2024 | Ethon Pharmaceuticals Ltda. | $69.425 |
| 900-667-SE24 | 04-06-2024 | Guillermo Harding y Compania Limitada | $6.544.881 |
| 900-664-SE24 | 04-06-2024 | Johnson y Johnson de Chile S.A. | $3.107.549 |
| 900-665-SE24 | 04-06-2024 | Farmaceutica Caribean SpA | $365.782 |
| 900-655-SE24 | 31-05-2024 | Guillermo Harding y Compania Limitada | $5.704.265 |
| 900-591-SE24 | 18-05-2024 | Farmaceutica Caribean SpA | $347.480 |
| 900-592-SE24 | 18-05-2024 | Laboratorio Chile S.A. | $1.130.500 |
| 900-590-SE24 | 16-05-2024 | Laboratorios Recalcine S.A. | $2.708.202 |
| 900-542-SE24 | 07-05-2024 | Guillermo Harding y Compania Limitada | $6.544.881 |
| 900-543-SE24 | 07-05-2024 | Farmaceutica Caribean SpA | $335.580 |
| 900-541-SE24 | 07-05-2024 | Johnson y Johnson de Chile S.A. | $2.514.506 |
| 900-478-SE24 | 25-04-2024 | Tecnofarma S.A. | $5.747.500 |
| 900-444-SE24 | 19-04-2024 | Guillermo Harding y Compania Limitada | $1.187.204 |
| 900-445-SE24 | 19-04-2024 | Laboratorios Andromaco S.A. | $139.230 |
| 900-443-SE24 | 19-04-2024 | Guillermo Harding y Compania Limitada | $3.866.013 |
| 900-397-SE24 | 08-04-2024 | Laboratorio Chile S.A. | $371.280 |
| 900-400-SE24 | 08-04-2024 | Ethon Pharmaceuticals Ltda. | $119.000 |
| 900-399-SE24 | 08-04-2024 | Farmaceutica Caribean SpA | $680.026 |
| 900-395-SE24 | 08-04-2024 | Ascend Laboratories SpA | $856.800 |
| 900-396-SE24 | 08-04-2024 | Laboratorios Recalcine S.A. | $2.427.600 |
| 900-398-SE24 | 08-04-2024 | Laboratorios Andromaco S.A. | $158.936 |
| 900-394-SE24 | 08-04-2024 | Guillermo Harding y Compania Limitada | $20.449.317 |
| 900-264-SE24 | 06-03-2024 | Guillermo Harding y Compania Limitada | $6.544.881 |
| 900-265-SE24 | 06-03-2024 | Laboratorios Recalcine S.A. | $1.751.085 |
| 900-266-SE24 | 06-03-2024 | Laboratorio Chile S.A. | $371.280 |
| 900-160-SE24 | 08-02-2024 | Guillermo Harding y Compania Limitada | $6.480.978 |
| 900-158-SE24 | 08-02-2024 | Ascend Laboratories SpA | $6.854.400 |
| 900-159-SE24 | 08-02-2024 | Laboratorios Recalcine S.A. | $2.631.090 |
| 900-85-SE24 | 17-01-2024 | Guillermo Harding y Compania Limitada | $185.759 |
| 900-24-SE24 | 09-01-2024 | Guillermo Harding y Compania Limitada | $8.652.837 |
| 900-7-SE24 | 09-01-2024 | Farmaceutica Caribean SpA | $178.705 |
| 900-3-SE24 | 06-01-2024 | Tecnofarma S.A. | $6.968.640 |
| 900-6-SE24 | 06-01-2024 | Laboratorio Biosano S.A. | $523.600 |
| 900-1-SE24 | 06-01-2024 | Laboratorios Recalcine S.A. | $3.315.102 |
| 900-2-SE24 | 06-01-2024 | Ascend Laboratories SpA | $5.712.000 |
| 900-23-SE24 | 06-01-2024 | Laboratorios Andromaco S.A. | $236.048 |
| 900-5-SE24 | 06-01-2024 | Guillermo Harding y Compania Limitada | $2.136.467 |
| 900-1515-SE23 | 22-12-2023 | Tecnofarma S.A. | $2.018.121 |
| 900-1516-SE23 | 22-12-2023 | Farmaceutica Caribean SpA | $3.427.200 |
| 900-1533-SE23 | 22-12-2023 | Laboratorio Chile S.A. | $1.761.200 |
| 900-1512-SE23 | 21-12-2023 | Laboratorios Recalcine S.A. | $1.672.664 |
| 900-1438-SE23 | 12-12-2023 | Laboratorio Chile S.A. | $8.806.000 |
| 900-1414-SE23 | 06-12-2023 | Tecnofarma S.A. | $4.036.242 |
| 900-1392-SE23 | 30-11-2023 | Ascend Laboratories SpA | $36.593 |
| 900-1385-SE23 | 30-11-2023 | Guillermo Harding y Compania Limitada | $793.511 |
| 900-1386-SE23 | 30-11-2023 | Farmaceutica Caribean SpA | $216.937 |
| 900-1387-SE23 | 30-11-2023 | Ethon Pharmaceuticals Ltda. | $173.562 |
| 900-1391-SE23 | 30-11-2023 | Indopharma S.A. | $2.284.800 |
| 900-1367-SE23 | 22-11-2023 | Guillermo Harding y Compania Limitada | $49.980 |
| 900-1332-SE23 | 14-11-2023 | Laboratorios Recalcine S.A. | $2.753.660 |
| 900-1225-SE23 | 20-10-2023 | Ethon Pharmaceuticals Ltda. | $166.195 |
| 900-1224-SE23 | 20-10-2023 | Laboratorios Recalcine S.A. | $1.363.740 |
| 900-1223-SE23 | 20-10-2023 | Farmaceutica Caribean SpA | $305.473 |
| 900-1183-SE23 | 17-10-2023 | Tecnofarma S.A. | $464.588 |
| 900-1159-SE23 | 10-10-2023 | Guillermo Harding y Compania Limitada | $5.156.765 |
| 900-1135-SE23 | 10-10-2023 | Laboratorio Chile S.A. | $2.261.000 |
| 900-1136-SE23 | 10-10-2023 | Guillermo Harding y Compania Limitada | $4.760.010 |
| 900-1157-SE23 | 10-10-2023 | Tecnofarma S.A. | $8.962.671 |
| 900-1138-SE23 | 27-09-2023 | Ascend Laboratories SpA | $340.340 |
| 900-1137-SE23 | 27-09-2023 | Farmaceutica Caribean SpA | $559.300 |
| 900-1125-SE23 | 25-09-2023 | Guillermo Harding y Compania Limitada | $3.458.200 |
| 900-1070-SE23 | 04-09-2023 | Farmaceutica Caribean SpA | $167.790 |
| 900-1071-SE23 | 04-09-2023 | Ascend Laboratories SpA | $136.136 |
| 900-809-SE23 | 30-08-2023 | Ethon Pharmaceuticals Ltda. | $156.373 |
| 900-804-SE23 | 21-08-2023 | Guillermo Harding y Compania Limitada | $4.753.753 |
| 900-807-SE23 | 21-08-2023 | Farmaceutica Caribean SpA | $3.427.200 |
| 900-952-SE23 | 16-08-2023 | Tecnofarma S.A. | $4.036.242 |
| 900-806-SE23 | 11-08-2023 | Laboratorio Biosano S.A. | $1.309.000 |
Fuente original:ficha mercadopublico.cl
